These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 15219888)
1. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development. Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888 [TBL] [Abstract][Full Text] [Related]
2. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423 [TBL] [Abstract][Full Text] [Related]
3. [Methylation status of FHIT gene in plasma and expression of FHIT gene in cancer tissue of cervical cancer patients]. Ren CC; Miao XH; Yang B; Zhao L; Sun R; Song WQ Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):565-7. PubMed ID: 17029211 [TBL] [Abstract][Full Text] [Related]
4. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation. Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840 [TBL] [Abstract][Full Text] [Related]
5. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma. Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242 [TBL] [Abstract][Full Text] [Related]
6. [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer]. Shi HR; Wu QH; Suo ZH; Nesland JM Ai Zheng; 2005 Jan; 24(1):7-11. PubMed ID: 15642192 [TBL] [Abstract][Full Text] [Related]
7. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma. Chen PM; Yang MH; Hsiao LT; Yu IT; Chu CJ; Chao TC; Yen CC; Wang WS; Chiou TJ; Liu JH Oncol Rep; 2004 Feb; 11(2):349-56. PubMed ID: 14719066 [TBL] [Abstract][Full Text] [Related]
8. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation. Hussain A; Gutiérrez MI; Timson G; Siraj AK; Deambrogi C; Al-Rasheed M; Gaidano G; Magrath I; Bhatia K Genes Chromosomes Cancer; 2004 Dec; 41(4):321-9. PubMed ID: 15384174 [TBL] [Abstract][Full Text] [Related]
9. 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer. Tzao C; Tsai HY; Chen JT; Chen CY; Wang YC Eur J Cancer; 2004 Sep; 40(14):2175-83. PubMed ID: 15341994 [TBL] [Abstract][Full Text] [Related]
10. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130 [TBL] [Abstract][Full Text] [Related]
11. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866 [TBL] [Abstract][Full Text] [Related]
12. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Hendricks DT; Taylor R; Reed M; Birrer MJ Cancer Res; 1997 Jun; 57(11):2112-5. PubMed ID: 9187105 [TBL] [Abstract][Full Text] [Related]
13. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer. Holschneider CH; Baldwin RL; Tumber K; Aoyama C; Karlan BY Clin Cancer Res; 2005 Aug; 11(16):5756-63. PubMed ID: 16115913 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768 [TBL] [Abstract][Full Text] [Related]
15. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma. Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140 [TBL] [Abstract][Full Text] [Related]
16. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782 [TBL] [Abstract][Full Text] [Related]
17. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines. Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495 [TBL] [Abstract][Full Text] [Related]
18. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines. Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors. Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420 [TBL] [Abstract][Full Text] [Related]
20. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]